Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue in COVID-19
IRCT20090701002113N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylene blue in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Death, PaO2/FiO2 and 4 more. Started Aug 2020; status: completed.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20090701002113N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090701002113N2.